Drug Database
Back to search

Netherlands· NL-846f1731a24a

Viread 33 mg/g, poeder voor oraal gebruik

A tenofovir disoproxil product containing tenofovirdisoproxilfumaraat, registered in Netherlands by Gilead Sciences Ireland UC. The same ATC class is registered in 15 of our 19 countries.

ATC J05AF07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedViread 33 mg/g, poeder voor oraal geb…ATCJ05AF07REGISTER NO.NL-846f1731a24aPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tenofovirdisoproxilfumaraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tenofovir disoproxil is registered in 15 of 19 countries.

Countries holding a registration under ATC J05AF07 (tenofovir disoproxil), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search tenofovir disoproxil products by name

Tenofovir disoproxil · ATC J05AF07

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tenofovir disoproxil costs, country by country.

Normalised to the WHO defined daily dose (0.245 g), the median price runs from $0.24 in United States to $14.17 in Switzerland — a ×59 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Tenofovir disoproxil · price per daily dose (0.245 g)

USD · FX 28 Sept 2026

  • CH Switzerland$14.17
  • FR France$4.15
  • US United States$0.24 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TENOFOVIRDISOPROXILFUMARAAT
Manufacturer
Gilead Sciences Ireland UC
Country
Netherlands (NL)
ATC code
J05AF07
ATC class
Tenofovir disoproxil
Defined daily dose
0.245 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/01/200

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for tenofovir disoproxil.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tenofovir disoproxil against other medicinesHow interaction checks work

Tenofovir disoproxil · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under J05AF07

Tenofovir disoproxil, as other registers publish it.

All tenofovir disoproxil products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c9d9204a-c23b-4a5d-9e56-32b761c0bc74
GET /v1/drugs/c9d9204a-c23b-4a5d-9e56-32b761c0bc74?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/viread-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Tenofovir Disoproxil",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp110940",
  "excipients": [
    "ETHYLCELLULOSE (E 462)",
    "HYPROLOSE (E 463)",
    "MANNITOL (D-) (E 421)",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "TENOFOVIRDISOPROXILFUMARAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2002/02/04",
  "procedure_number": "EMEA/H/C/000419",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/01/200",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about tenofovir disoproxil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console